2023
Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Ferrarotto R, Nagarajan P, Maronge J, Johnson J, Rosenthal D, Myers J, Gross N. Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngology - Head & Neck Surgery 2023, 149: 847-849. PMID: 37535378, PMCID: PMC10401391, DOI: 10.1001/jamaoto.2023.1729.Peer-Reviewed Original Research
2022
Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study
Ng S, Cardenas C, Bahig H, Elgohari B, Wang J, Johnson J, Moreno A, Shah S, Garden A, Phan J, Gunn G, Frank S, Ding Y, Na L, Yuan Y, Urbauer D, Mohamed A, Rosenthal D, Morrison W, MacManus M, Fuller C. Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study. Current Oncology 2022, 29: 6303-6313. PMID: 36135064, PMCID: PMC9498049, DOI: 10.3390/curroncol29090495.Peer-Reviewed Original ResearchConceptsApparent diffusion coefficientPost-treatment MRIT3-T4 tumorsIntact primary tumorSquamous cell carcinomaT1-T2 tumorsDifferent treatment responsesNodal diseaseOropharyngeal cancerClinical featuresSpearman correlation coefficientCell carcinomaNeck cancerPrimary tumorNeck radiotherapyNodal sitesTreatment responseWeek 4Weekly MRIPatientsMR biomarkersGTV sizeNodal volumeADC valuesTumors
2020
Changes In Apparent Diffusion Coefficient (ADC) In Serial Weekly MRI During Radiotherapy In Patients With Head And Neck Cancer: Results From The PREDICT-HN Study
Ng S, Cardenas C, Bahig H, Elgohari B, Wang J, Johnson J, Moreno A, Shah S, Garden A, Phan J, Gunn G, Frank S, Ding Y, Na L, Yuan Y, Urbauer D, Rosenthal D, Morrison W, MacManus M, Fuller C. Changes In Apparent Diffusion Coefficient (ADC) In Serial Weekly MRI During Radiotherapy In Patients With Head And Neck Cancer: Results From The PREDICT-HN Study. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e790-e791. DOI: 10.1016/j.ijrobp.2020.07.264.Peer-Reviewed Original ResearchComparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases
Ng S, Cardenas C, Elhalawani H, Pollard C, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson J, Kamal M, Garden A, Reddy J, Su S, Ferrarotto R, Frank S, Gunn G, Moreno A, Rosenthal D, Fuller C, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Physics And Imaging In Radiation Oncology 2020, 14: 1-5. PMID: 33458306, PMCID: PMC7807720, DOI: 10.1016/j.phro.2020.04.001.Peer-Reviewed Original ResearchMagnetic resonance imagingHigh interobserver agreementInterobserver agreementRe-irradiation casesSkull base sitesTumor delineationRecurrent HNCMultiple imaging modalitiesTumor volumeRadiation oncologistsResonance imagingDual energyInterobserver consistencyImaging modalitiesTreatment planningMedian DSCTomographyMagnetic resonancePatientsOncologistsTumorsDECTHead
2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy
Ng S, Pollard C, Berends J, Ayoub Z, Kamal M, Garden A, Bahig H, Cantor S, Schaefer A, Ajayi T, Gunn G, Frank S, Skinner H, Phan J, Morrison W, Ferrarotto R, Johnson J, Mohamed A, Lai S, Hessel A, Sturgis E, Weber R, Fuller C, Rosenthal D. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer 2019, 125: 1823-1829. PMID: 30748005, PMCID: PMC7234834, DOI: 10.1002/cncr.31983.Peer-Reviewed Original ResearchConceptsDisease recurrenceAsymptomatic patientsOverall survivalClinical findingsNeck cancerAdverse clinical findingsLocoregional disease recurrenceMedian imaging followUsefulness of surveillanceDisease-free intervalMedian overall survivalDistant disease recurrenceGroup of patientsEfficacy of surveillanceTreatment of HNCEligible patientsSalvage therapySalvageable recurrenceDefinitive radiotherapyMedian timeSuspicious findingsPatientsRecurrenceRadiotherapyEarly detection
2018
Cost of Surveillance Imaging in Head and Neck Cancer Patients Treated With Definitive Radiation therapy
Ng S, Kamal M, Pollard C, Berends J, Ayoub Z, Mohamed A, Gunn G, Frank S, Skinner H, Phan J, Morrison W, Rosenthal D, Garden A, Johnson J, Lai S, Sturgis E, Fuller C. Cost of Surveillance Imaging in Head and Neck Cancer Patients Treated With Definitive Radiation therapy. International Journal Of Radiation Oncology • Biology • Physics 2018, 100: 1387-1388. DOI: 10.1016/j.ijrobp.2017.12.208.Peer-Reviewed Original ResearchSecond Primary Malignancies in Head and Neck Cancer Patients Treated With Definitive Radiation Therapy
Ng S, Kamal M, Pollard C, Berends J, Ayoub Z, Mohamed A, Gunn G, Frank S, Skinner H, Phan J, Morrison W, Garden A, Johnson J, Ferrarotto R, Lai S, Sturgis E, Fuller C, Rosenthal D. Second Primary Malignancies in Head and Neck Cancer Patients Treated With Definitive Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2018, 100: 1352. DOI: 10.1016/j.ijrobp.2017.12.119.Peer-Reviewed Original Research
2017
Cognitive function and patient‐reported memory problems after radiotherapy for cancers at the skull base: A cross‐sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory‐Head and Neck Module
Hansen C, Smith J, Mohamed A, Mulcahy C, Wefel J, Hutcheson K, Chrane K, Phan J, Frank S, Garden A, Smith B, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle B, Morrison W, Su S, Lewis C, Kupferman M, Johnson J, Skinner H, Lai S, Hanna E, Rosenthal D, Fuller C, Gunn G, Group A. Cognitive function and patient‐reported memory problems after radiotherapy for cancers at the skull base: A cross‐sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory‐Head and Neck Module. Head & Neck 2017, 39: 2048-2056. PMID: 28763137, PMCID: PMC6082378, DOI: 10.1002/hed.24876.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedArea Under CurveCentral Nervous SystemCognitionCognitive DysfunctionCross-Sectional StudiesFemaleHealth Status IndicatorsHumansInterviews as TopicMaleMass ScreeningMemory DisordersMiddle AgedPatient Reported Outcome MeasuresRadiation InjuriesSeverity of Illness IndexSkull BaseSkull Base NeoplasmsSurvivorshipYoung AdultConceptsMD Anderson Symptom Inventory-HeadDetectable cognitive impairmentCognitive dysfunctionCognitive impairmentNeck ModuleCognitive statusTelephone interviewsPatient-reported problemsThird of patientsSkull base cancerRecursive partition analysisObjective assessment toolCognitive symptomsCutoff pointSkull baseCognitive functionSurvivorship studiesScreening toolMemory complaintsObjective cognitive dysfunctionImpairmentSevere levelsMDASIPatientsDysfunction